CISEN PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.84 CNY | -0.25% |
|
+3.94% | +8.20% |
| Apr. 23 | Cisen Pharmaceutical Names Chief Financial Officer | MT |
| Apr. 22 | Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Cisen Pharmaceutical Co., Ltd is a China-based company principally involved in the research, development, manufacturing and sales of medical products. The Company operates through two main segments. The Main Business segment is primarily involved in the manufacturing and sales of medicine, among which include infusion, freeze-dried powder, small volume injection, tablet, capsules, ointment, drops and active pharmaceutical ingredients, among others. The Other Business segment is mainly involved in the sales of raw materials and houses tenancy.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +8.20% | 992M | |
| +20.81% | 43.34B | |
| +22.75% | 21.96B | |
| +13.30% | 14.09B | |
| +12.97% | 13.64B | |
| +39.74% | 11.43B | |
| -10.75% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +9.64% | 5.22B |
- Stock Market
- Equities
- 603367 Stock
- News Cisen Pharmaceutical Co., Ltd.
- Cisen Pharmaceutical Secures Regulatory Approval for Methylcobalamin Tablets
